Contents

CNS & Neurological Disorders - Drug Targets , Volume 5 - Number 2

Editorial [Hot Topic: Neuropeptide Systems as Novel Targets for Psychiatric Disorders (Guest Editor: Guy Griebel) ]

, 5(2): 133

Guy Griebel


DOI: 10.2174/187152706776359637




Neuropeptides in Psychiatric Diseases: An Overview with a Particular Focus on Depression and Anxiety Disorders

, 5(2): 135 - 145

A. Surget, S. Leman, G. Griebel, C. Belzung and I. Yalcin


DOI: 10.2174/187152706776359682




Corticotropin-Releasing Factor Receptor Antagonists in Affective Disorders and Drug Dependence - An Update

, 5(2): 147 - 165

Frank M. Dautzenberg and Thomas Steckler


DOI: 10.2174/187152706776359619




The Involvement of the Vasopressin System in Stress-Related Disorders

, 5(2): 167 - 179

Rainer Landgraf


DOI: 10.2174/187152706776359664




Neuropeptide Y: Role in Emotion and Alcohol Dependence

, 5(2): 181 - 195

R. Quirion, Y. Dumont and C. Carvajal


DOI: 10.2174/187152706776359592




Gastrin-Releasing Peptide Receptor as a Molecular Target for Psychiatric and Neurological Disorders

, 5(2): 197 - 204

G. Schwartsmann, J. A.P. Henriques and R. Roesler


DOI: 10.2174/187152706776359673




Novel Treatments of Schizophrenia: Targeting the Neurotensin System

, 5(2): 205 - 218

B. Kinkead and C. B. Nemeroff


DOI: 10.2174/187152706776359655




The Orphanin FQ / Nociceptin Receptor as a Novel Drug Target in Psychiatric Disorders

, 5(2): 219 - 224

Rainer K. Reinscheid


DOI: 10.2174/187152706776359628




Galanin: A Novel Therapeutic Target for Depression, Anxiety Disorders and Drug Addiction?

, 5(2): 225 - 232

A. Holmes and M. R. Picciotto


DOI: 10.2174/187152706776359600




Alcoholism and Neuropeptides: An Update

, 5(2): 233 - 239

M. S. Cowen and A. J. Lawrence


DOI: 10.2174/187152706776359646




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science